Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 46 results:
Συντάκτης [ Τίτλος(Desc)] Τύπος Έτος
Φίλτρα: Συντάκτης is Kotoula, Vassiliki  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
M
Carvajal-Hausdorf, D. E., Patsenker J., Stanton K. P., Villarroel-Espindola F., Esch A., Montgomery R. R., et al. (2019).  Multiplexed (18-Plex) Measurement of Signaling Targets and Cytotoxic T Cells in Trastuzumab-Treated Patients using Imaging Mass Cytometry.. Clin Cancer Res. 25(10), 3054-3062.
Gogas, H., Kotoula V., Alexopoulou Z., Christodoulou C., Kostopoulos I., Bobos M., et al. (2016).  MYC copy gain, chromosomal instability and PI3K activation as potential markers of unfavourable outcome in trastuzumab-treated patients with metastatic breast cancer.. J Transl Med. 14(1), 136.
N
Sotiriou, S., Koletsa T., Tzorakoleftheraki S-E., Kotoula V., Mantalovas S., & Kostopoulos I. (2019).  Nodal mesenteric marginal zone lymphoma with amyloid deposits, calcification, and ossification. Journal of Hematopathology. 1221237811413(133666), 25 - 26.
O
Kotoula, V., & Fountzilas G. (2016).  Overview of advances in cancer immunotherapy.. Ann Transl Med. 4(14), 260.
P
Karavasilis, V., Kotoula V., Pentheroudakis G., Televantou D., Lambaki S., Chrisafi S., et al. (2013).  A phase I study of temozolomide and lapatinib combination in patients with recurrent high-grade gliomas.. J Neurol. 260(6), 1469-80.
Kotoula, V., Fostira F., & Fountzilas E. (2019).  Primary Resistance to Immune Checkpoint Inhibitors in Metastatic Colorectal Cancer-Beyond the Misdiagnosis.. JAMA Oncol. 5(5), 740-741.
Economopoulou, P., Kotoula V., Koliou G-A., Papadopoulou K., Christodoulou C., Pentheroudakis G., et al. (2019).  Prognostic Impact of Src, CDKN1B, and JAK2 Expression in Metastatic Breast Cancer Patients Treated with Trastuzumab.. Transl Oncol. 12(5), 739-748.
Fountzilas, E., Kotoula V., Pentheroudakis G., Manousou K., Polychronidou G., Vrettou E., et al. (2019).  Prognostic implications of mismatch repair deficiency in patients with nonmetastatic colorectal and endometrial cancer.. ESMO Open. 4(2), e000474.
Fountzilas, E., Kotoula V., Tikas I., Manousou K., Papadopoulou K., Poulios C., et al. (2018).  Prognostic significance of tumor genotypes and CD8+ infiltrates in stage I-III colorectal cancer.. Oncotarget. 9(86), 35623-35638.
Strati, T-M., Kotoula V., Kostopoulos I., Manousou K., Papadimitriou C., Lazaridis G., et al. (2017).  Prognostic Subcellular Notch2, Notch3 and Jagged1 Localization Patterns in Early Triple-negative Breast Cancer.. Anticancer Res. 37(5), 2323-2334.
Poulaki, V., Mitsiades C. S., Kotoula V., Negri J., McMillin D., Miller J. W., et al. (2007).  The proteasome inhibitor bortezomib induces apoptosis in human retinoblastoma cell lines in vitro.. Invest Ophthalmol Vis Sci. 48(10), 4706-19.
R
Poulaki, V., Mitsiades C. S., Kotoula V., Tseleni-Balafouta S., Ashkenazi A., Koutras D. A., et al. (2002).  Regulation of Apo2L/tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in thyroid carcinoma cells.. Am J Pathol. 161(2), 643-54.
Poulaki, V., Mitsiades C. S., McMullan C., Sykoutri D., Fanourakis G., Kotoula V., et al. (2003).  Regulation of vascular endothelial growth factor expression by insulin-like growth factor I in thyroid carcinomas.. J Clin Endocrinol Metab. 88(11), 5392-8.
Kotoula, V., Papamichos S. I., & Lambropoulos A. F. (2008).  Revisiting OCT4 expression in peripheral blood mononuclear cells.. Stem Cells. 26(1), 290-1.
S
Kotoula, V., Kalogeras K. T., Kouvatseas G., Televantou D., Kronenwett R., Wirtz R. M., et al. (2013).  Sample parameters affecting the clinical relevance of RNA biomarkers in translational breast cancer research.. Virchows Arch. 462(2), 141-54.
Athanassiadou, F., Tragiannidis A., Kourti M., Papageorgiou T., Kotoula V., Kontopoulos V., et al. (2006).  Spinal epidural extraskeletal Ewing sarcoma in an adolescent boy: a case report.. Pediatr Hematol Oncol. 23(3), 263-7.
Koletsa, T., Kostopoulos I., Charalambous E., Christoforidou B., Nenopoulou E., & Kotoula V. (2008).  A splice variant of HER2 corresponding to Herstatin is expressed in the noncancerous breast and in breast carcinomas.. Neoplasia. 10(7), 687-96.
T
Fountzilas, G., Christodoulou C., Bobos M., Kotoula V., Eleftheraki A. G., Xanthakis I., et al. (2012).  Topoisomerase II alpha gene amplification is a favorable prognostic factor in patients with HER2-positive metastatic breast cancer treated with trastuzumab.. J Transl Med. 10, 212.
Kourea, H., & Kotoula V. (2016).  Towards tumor immunodiagnostics.. Ann Transl Med. 4(14), 263.
Fountzilas, E., Levva S., Mountzios G., Polychronidou G., Maniadakis N., Kotoula V., et al. (2018).  Treating EGFR-Mutated Oncogene-Addicted Advanced Non-Small-Cell Lung Cancer in the Era of Economic Crisis in Greece: Challenges and Opportunities.. J Glob Oncol. 4, 1-12.
Chatzopoulos, K., Kotoula V., Manoussou K., Markou K., Vlachtsis K., Angouridakis N., et al. (2020).  Tumor Infiltrating Lymphocytes and CD8+ T Cell Subsets as Prognostic Markers in Patients with Surgically Treated Laryngeal Squamous Cell Carcinoma.. Head Neck Pathol. 14(3), 689-700.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.

           

Σύνδεσμοι

 

Το πανεπιστήμιο

 
 

Προσωπικό & Φοιτητές